3M acquired Acelity Inc. and its KCI subsidiaries worldwide, a leading global medical technology company focused on advanced wound care and specialty surgical applications marketed under the KCI brand, for a total enterprise value of approximately $6.7 billion including assumption of debt. $6.7 billion enterprise value (approx. $4.5 billion net of cash acquired plus assumption of debt).
- 01 Recognized global leader in advanced wound care under the KCI brand
- 02 complementing 3M's existing Health Care portfolio in a significant and growing market
Acelity is a recognized leading provider of advanced wound care technologies and solutions and an excellent complement to our Health Care business. This acquisition bolsters our Medical Solutions business and supports our growth strategy to offer comprehensive advanced and surgical wound care solutions to improve outcomes and enhance the patient and provider experience.
This is an exciting day as we bring together two premier and innovative companies that are focused on delivering comprehensive health care solutions to enable better outcomes for patients. This addition further accelerates 3M as a leader in advanced wound care, which is a significant and growing market segment.
Acelity is reported within 3M's Health Care business; 3M assumed debt in connection with the acquisition, a portion of which was redeemed or paid at close.